# Recursion Pharmaceuticals, Inc. (RXRX): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/rxrx for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Recursion Pharmaceuticals, Inc. operates as a biotechnology firm currently in its clinical development phase. The company's mission is to revolutionize drug discovery by decoding biological processes, utilizing an integrated approach that combines technological innovations across biology, chemistry, automation, data science, and engineering. Their developmental pipeline features several clinical-stage compounds: REC-994, which is advancing through Phase IIa trials for cerebral cavernous malformation; REC-3599, currently in Phase I trials for GM2 gangliosidosis; REC-2282, aimed at treating n...

## Quote & Key Metrics

As of 2026-10-27:

| Metric | Value |
|---|---|
| Price | $4.03 USD |
| Market Cap | $2.15B |
| P/E (TTM) | — |
| EPS (TTM) | −$1.04 |
| 52-Week Range | $2.77 – $6.25 |
| Dividend Yield (TTM) | — |

## Dividend

RXRX has no dividend payment history in our records.

## Frequently Asked Questions

### What does Recursion Pharmaceuticals, Inc. do?

Recursion Pharmaceuticals, Inc. (RXRX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is RXRX's market cap?

Recursion Pharmaceuticals, Inc. (RXRX) has a market capitalization of approximately $2.15 billion, as of October 27, 2026, based on the most recent share price and shares outstanding.

### Does RXRX pay a dividend?

No, Recursion Pharmaceuticals, Inc. (RXRX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is RXRX profitable?

Recursion Pharmaceuticals, Inc. (RXRX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has RXRX ever paid a dividend?

No. Dividend Data's records show no dividend payments from Recursion Pharmaceuticals, Inc. (RXRX). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/rxrx
- Dividend history & safety: https://www.dividenddata.com/stocks/rxrx/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/rxrx/earnings
- Financial statements: https://www.dividenddata.com/stocks/rxrx/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/rxrx/valuation
- Peer comparison: https://www.dividenddata.com/stocks/rxrx/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.